Breast Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Breast Ultrasound Market size stood at USD 2.9 billion in 2026 and is predicted to grow at a 13.49% CAGR from 2027 to 2036, reaching USD 10.28 billion by 2036. The industry revenue for 2027 is calculated at USD 3.23 billion.
Get more details on this report
Request Free Sample ReportBreast Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for a 37.84% market share in 2026, supported by advanced diagnostic imaging infrastructure, established screening pathways, and routine ultrasound use across hospitals and imaging centers.
- Asia Pacific is expected to expand at a 15.68% CAGR as diagnostic access improves, hospital capacity grows, and ultrasound adoption increases across routine breast screening and follow-up care.
Segment Momentum
- ABUS accounted for 62.18% of the market in 2026 by delivering standardized image acquisition, consistent workflows, and reliable examinations that support efficient screening and diagnostic imaging across healthcare facilities.
- Diagnostics Imaging Laboratories are expanding fastest as demand grows for specialized imaging services offering streamlined workflows, higher imaging throughput, appointment efficiency, and dedicated diagnostic environments.
Market Expansion Drivers
- Rising breast cancer incidence and screening awareness driving diagnostic imaging demand.
- Growing adoption of automated breast ultrasound and AI-enabled imaging systems.
- Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers.
Leading Market Participants
- Key players in the breast ultrasound market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Hologic, Inc. (United States), FUJIFILM Holdings Corporation (Japan), SuperSonic Imagine SA (France), Delphinus Medical Technologies, Inc. (United States), Fukuda Denshi Co., Ltd. (Japan), Lunit Inc. (South Korea).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.9 billion
- 2027 Estimated Market Size: USD 3.23 billion.
- Projected Market Size: USD 10.28 billion by 2036
- Growth Forecast: 13.49% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Automated Breast Ultrasound (ABUS) (Product) | Hospital (End Use)
- Emerging Opportunity Segment: Conventional Breast Ultrasound (CBUS) (Product) | Diagnostics Imaging Laboratories (End Use)
Market Growth Drivers and Industry Trends
Rising breast cancer incidence and screening awareness driving diagnostic imaging demand
Increasing awareness of breast cancer screening and the need for earlier detection are strengthening diagnostic imaging requirements, supporting the breast ultrasound market growth across healthcare settings. Breast ultrasound provides a non-invasive imaging option that can complement other breast examination methods, particularly when further evaluation of suspicious findings or dense breast tissue is required. Greater public awareness of routine screening and increasing attention to early diagnosis are encouraging healthcare providers to expand diagnostic capabilities. Its ability to support real-time examination without ionizing radiation also makes ultrasound a useful modality for repeated assessment and targeted evaluation of breast abnormalities.
Growing adoption of automated breast ultrasound and AI-enabled imaging systems
Technological advances are reshaping breast imaging workflows, and the breast ultrasound market will benefit from greater adoption of automated systems and artificial intelligence-enabled capabilities. Automated breast ultrasound can improve examination consistency by systematically capturing breast images, while AI-based tools can assist clinicians in identifying and characterizing potentially abnormal findings. These technologies can support more efficient image interpretation, reduce variability associated with manual examinations, and help integrate advanced imaging into screening and diagnostic workflows. Increasing interest in digital healthcare and computer-assisted diagnostics is encouraging providers to evaluate these systems for improving clinical efficiency and imaging support.
Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers
The expansion of decentralized healthcare delivery is creating additional opportunities for breast imaging outside traditional hospital environments, which will boost the breast ultrasound market demand. Outpatient facilities and mobile diagnostic centers can use ultrasound systems to provide breast examinations closer to patients, improving access for populations that may face geographic or logistical barriers to hospital-based imaging. Portable and compact ultrasound equipment also supports deployment in locations where large imaging infrastructure may not be practical. Greater emphasis on convenient diagnostic services and earlier clinical evaluation is encouraging healthcare providers to incorporate breast imaging into community-based and ambulatory care models.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising breast cancer incidence and screening awareness driving diagnostic imaging demand | 2.20% | High | North America, Europe | High | Near Term |
| Growing adoption of automated breast ultrasound and AI-enabled imaging systems | 2.00% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expansion of point-of-care breast imaging in outpatient and mobile diagnostic centers | 1.60% | Moderate | Asia Pacific, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the breast ultrasound market at 37.84% in 2026, supported by advanced diagnostic infrastructure, strong adoption of breast imaging technologies, and growing emphasis on early detection. Healthcare providers are increasingly integrating ultrasound into breast assessment pathways, particularly where supplemental imaging is needed to improve diagnostic evaluation. The region's established network of hospitals and diagnostic centers, combined with access to advanced imaging equipment and skilled medical professionals, supports consistent utilization. Continued focus on improving diagnostic accuracy and expanding access to non-invasive imaging is further strengthening regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, driven by expanding healthcare infrastructure, rising awareness of breast health, and improving access to diagnostic services. Increasing investment in hospitals and imaging centers is enabling broader adoption of ultrasound technologies, while greater emphasis on early diagnosis is encouraging more women to seek screening and diagnostic evaluation. Growing healthcare expenditure and modernization of medical facilities are also supporting the deployment of advanced imaging systems. As diagnostic capabilities become more accessible across developing healthcare markets, demand for breast ultrasound is gaining momentum throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic SupportGermany emphasizes breast ultrasound as an important complementary imaging modality, particularly for patients requiring additional diagnostic evaluation. Investments are directed toward high-resolution systems and efficient integration within hospital imaging departments.
France 🇫🇷
Structured Diagnostic PathwaysFrance utilizes breast ultrasound as part of coordinated diagnostic pathways that support comprehensive breast care. Demand is centered on systems that improve examination efficiency and provide reliable imaging for supplemental assessments.
Italy 🇮🇹
Expanding Imaging AccessibilityItaly is focusing on improving access to breast imaging services through broader deployment of ultrasound equipment across healthcare settings. Providers are seeking versatile systems that support both routine examinations and specialized diagnostic requirements.
Japan 🇯🇵
High-Resolution Screening ToolsJapan is prioritizing advanced breast ultrasound technologies that enhance screening accuracy and support dense breast assessment. Healthcare facilities continue to adopt compact and high-performance systems suited to routine diagnostic workflows.
South Korea 🇰🇷
Technology-Driven ScreeningSouth Korea's breast ultrasound market is characterized by rapid adoption of technologically advanced imaging platforms. Providers are incorporating artificial intelligence and improved visualization tools to strengthen diagnostic confidence and patient management.
United States 🇺🇸
Advanced Imaging IntegrationThe U.S. breast ultrasound market is increasingly focused on integrating advanced imaging technologies into screening and diagnostic pathways. Healthcare providers are adopting systems with improved image quality and workflow capabilities to support early detection initiatives.
Segment Leadership and Growth Trends
Breast Ultrasound Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Automated Breast Ultrasound (ABUS) (Largest Segment) vs Conventional Breast Ultrasound (CBUS) (Fastest-Growing Segment)
Automated breast ultrasound (ABUS) accounted for 62.18% share in 2026, making it the leading product segment in the breast ultrasound market. Its automated scanning approach supports more standardized breast imaging and can improve workflow consistency compared with highly operator-dependent examination methods. Growing interest in reproducible imaging, screening efficiency, and advanced diagnostic workflows is reinforcing adoption of automated ultrasound technologies.
Conventional breast ultrasound (CBUS) is the fastest-growing product segment as healthcare providers continue to value the flexibility of operator-guided imaging for targeted breast evaluation. Its ability to support real-time assessment and focused examination of specific areas makes it useful in diagnostic settings, while broader access to ultrasound equipment and continued demand for complementary breast imaging are supporting its expanding utilization.
End Use Segment Analysis: Hospital (Largest Segment) vs Diagnostics Imaging Laboratories (Fastest-Growing Segment)
Hospitals dominated the breast ultrasound market with a 51.41% share in 2026, reflecting their central role in breast disease diagnosis, screening, treatment planning, and follow-up care. Hospitals offer access to multidisciplinary clinical teams and complementary diagnostic resources, allowing breast ultrasound to be integrated into broader patient evaluation pathways and supporting consistent demand for imaging services.
Diagnostics imaging laboratories represent the fastest-growing end-use segment as diagnostic services increasingly expand beyond traditional hospital settings. Specialized imaging facilities can provide focused examination services, streamlined workflows, and convenient access to diagnostic testing, supporting greater utilization of breast ultrasound as demand for accessible and timely imaging continues to increase.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Conventional Breast Ultrasound (CBUS), Automated Breast Ultrasound (ABUS) | Automated Breast Ultrasound (ABUS) | Conventional Breast Ultrasound (CBUS) |
| End Use | Hospital, Diagnostics Imaging Laboratories, Others | Hospital | Diagnostics Imaging Laboratories |
Competitive Landscape and Market Positioning
Top players in the breast ultrasound market:
1. GE HealthCare Technologies Inc. (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. Siemens Healthineers AG (Germany)
4. Canon Medical Systems Corporation (Japan)
5. Hologic Inc. (United States)
6. FUJIFILM Holdings Corporation (Japan)
7. SuperSonic Imagine SA (France)
8. Delphinus Medical Technologies Inc. (United States)
9. Fukuda Denshi Co. Ltd. (Japan)
10. Lunit Inc. (South Korea)
The breast ultrasound market is advancing with improvements in imaging resolution and diagnostic precision. Innovation in portable and high-frequency ultrasound systems is enhancing clinical usability. Continuous development in imaging algorithms is supporting more accurate and early-stage detection capabilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Hologic Inc. (United States) | |||||||
| FUJIFILM Holdings Corporation (Japan) | |||||||
| SuperSonic Imagine SA (France) | |||||||
| Delphinus Medical Technologies Inc. (United States) | |||||||
| Fukuda Denshi Co. Ltd. (Japan) | |||||||
| Lunit Inc. (South Korea). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Samsung Medison | May-26 | Samsung Medison formed a strategic partnership with HistoSonics to integrate its R20 ultrasound system with the Edison platform. This collaboration enables seamless connectivity between diagnostic imaging and therapeutic ultrasound technologies, marking a strategic expansion for Samsung into the emerging field of ultrasound-guided, non-invasive therapeutic interventions. |
| iSono Health | Apr-26 | iSono Health commercially launched ATUSA, an FDA-cleared, wearable 3D breast ultrasound system. This automated platform is designed to decentralize breast imaging by reducing reliance on specialized sonographers and conventional hospital-based infrastructure, representing a significant shift toward portable, high-throughput breast cancer screening accessibility. |
| RadNet | Apr-26 | RadNet, through its DeepHealth subsidiary, acquired See-Mode Technologies to incorporate AI-powered ultrasound imaging solutions into its clinical operations. This strategic acquisition enhances RadNet's diagnostic capabilities and strengthens its position in the competitive AI-driven medical imaging market, facilitating more efficient ultrasound interpretation and clinical workflow integration. |
| GE HealthCare | Apr-26 | GE HealthCare launched the Ivenia ABUS Premium, an AI-enhanced automated breast ultrasound system. The platform is engineered to optimize supplemental breast screening workflows, improving diagnostic throughput and imaging consistency. This release underscores the company’s strategic commitment to leveraging artificial intelligence to address clinical inefficiencies in large-scale breast cancer screening programs. |
| iCAD | Apr-26 | iCAD entered a strategic reseller partnership with Koios Medical to integrate AI-driven diagnostic technologies across mammography and ultrasound platforms. This initiative creates a multi-modality breast cancer detection ecosystem, allowing for more cohesive diagnostic workflows that improve clinical decision-making from initial screening through to final assessment. |
| BeamWorks | Apr-26 | BeamWorks secured regulatory approval in South Korea for its CadAI-B software, an AI-assisted diagnostic tool for breast cancer detection. The regulatory clearance facilitates the commercial deployment of advanced, software-based diagnostic support in clinical environments, contributing to the broader market trend toward AI-augmented breast imaging and improved diagnostic precision. |
| USM Hospital | Apr-26 | USM Hospital deployed GE HealthCare’s Invenia ABUS 2.0, marking the first installation of this automated breast ultrasound system on Malaysia’s east coast. This strategic infrastructure investment significantly upgrades the region’s breast cancer screening capacity, reflecting a broader trend of expanding access to advanced, standardized automated ultrasound technology in emerging healthcare markets. |
| Lily MedTech | Apr-26 | Lily MedTech announced advancements in its breast imaging portfolio, specifically focusing on ultrasound mammogram technology. This development aims to enhance early-stage breast cancer detection by utilizing ultrasound-based screening as a primary modality, challenging conventional diagnostic paradigms and signaling a potential shift in long-term breast imaging clinical practices. |
| Hologic, Inc. | Nov-23 | Hologic, Inc. introduced Genius AI Detection 2.0, an advanced software solution designed to improve breast cancer detection rates while simultaneously reducing false-positive markings. The release serves as a strategic update to the company's AI-driven diagnostic portfolio, improving the accuracy of clinical screening workflows and enhancing the competitive utility of its imaging hardware. |
| Hologic, Inc. | Sep-23 | Hologic, Inc. partnered with Bayer to jointly develop and distribute contrast-enhanced mammography (CEM) solutions globally. This strategic alliance combines Hologic’s imaging hardware expertise with Bayer’s contrast media capabilities, aiming to expand diagnostic options for breast cancer detection and address the specific imaging needs of patients with dense breast tissue. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Breast Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Use | Screening, Diagnostic Evaluation, Biopsy Guidance & Interventional Procedures, Treatment Monitoring |
| Procurement Model | Direct Capital Purchase, Leasing & Equipment Financing, Managed Equipment Services, Pay-Per-Use & Outsourced Imaging |
| Operator Type | Radiologists, Sonographers, Breast Surgeons & Specialists, Other Trained Clinical Personnel |
Breast Ultrasound Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Breast Imaging Workflow Optimization Analysis |
|
| Screening Program Expansion Opportunities |
|
| AI Integration Impact Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow large is the breast ultrasound market?
What is the anticipated CAGR of the breast ultrasound industry?
How are automation and AI influencing purchasing decisions in the breast ultrasound market?
Why is point-of-care imaging accelerating growth in the breast ultrasound market?
Why is Automated Breast Ultrasound (ABUS) the largest product segment in the breast ultrasound market?
Why are Diagnostics Imaging Laboratories the fastest-growing end-use segment in the breast ultrasound market?
Why does North America lead the breast ultrasound market?
What factors are accelerating breast ultrasound market growth in Asia Pacific?
Who holds a significant market share in the breast ultrasound landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization